These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 3711098)
1. Purification and chemical composition of gpL115, the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. Remold-O'Donnell E; Davis AE; Kenney D; Bhaskar KR; Rosen FS J Biol Chem; 1986 Jun; 261(16):7526-30. PubMed ID: 3711098 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. Remold-O'Donnell E; Kenney DM; Parkman R; Cairns L; Savage B; Rosen FS J Exp Med; 1984 Jun; 159(6):1705-23. PubMed ID: 6547160 [TBL] [Abstract][Full Text] [Related]
3. Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Remold-O'Donnell E; Zimmerman C; Kenney D; Rosen FS Blood; 1987 Jul; 70(1):104-9. PubMed ID: 2439146 [TBL] [Abstract][Full Text] [Related]
4. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. Lefebvre JC; Giordanengo V; Limouse M; Doglio A; Cucchiarini M; Monpoux F; Mariani R; Peyron JF J Exp Med; 1994 Nov; 180(5):1609-17. PubMed ID: 7964449 [TBL] [Abstract][Full Text] [Related]
5. Characterization of a 95 kDa human leucocyte sialoglycoprotein: its identity with CD43, gpL115, leukosialin and sialophorin. Stefanová I; Hilgert I; Angelisová P; Kristofová H; Horejsí V Folia Biol (Praha); 1988; 34(4):255-65. PubMed ID: 2467832 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Shelley CS; Remold-O'Donnell E; Davis AE; Bruns GA; Rosen FS; Carroll MC; Whitehead AS Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2819-23. PubMed ID: 2784859 [TBL] [Abstract][Full Text] [Related]
8. Biosynthesis of human sialophorins and analysis of the polypeptide core. Remold-O'Donnell E; Kenney D; Rosen FS Biochemistry; 1987 Jun; 26(13):3908-13. PubMed ID: 3115291 [TBL] [Abstract][Full Text] [Related]
9. Molecular heterogeneity of a lymphocyte glycoprotein in immunodeficient patients. Reisinger D; Parkman R J Clin Invest; 1987 Feb; 79(2):595-9. PubMed ID: 3805282 [TBL] [Abstract][Full Text] [Related]
10. Isolation and partial characterization of the major sialoglycoprotein of human T-lymphoblastoid cells of a MOLT-4B cell line. Saito M; Toyoshima S; Osawa T Biochem J; 1978 Dec; 175(3):823-31. PubMed ID: 311197 [TBL] [Abstract][Full Text] [Related]
11. The large sialoglycoprotein of human lymphocytes. II. Biochemical features. Axelsson B; Hammarström S; Finne J; Perlmann P Eur J Immunol; 1985 May; 15(5):427-33. PubMed ID: 3873337 [TBL] [Abstract][Full Text] [Related]
12. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome. Piller F; Le Deist F; Weinberg KI; Parkman R; Fukuda M J Exp Med; 1991 Jun; 173(6):1501-10. PubMed ID: 2033371 [TBL] [Abstract][Full Text] [Related]
13. CD43 (leukosialin, sialophorin, large sialoglycoprotein) can be expressed in both normal and Wiskott-Aldrich fibroblasts via transfection of a leukosialin cDNA. Pallant A; Fukuda M; Frelinger JG Eur J Immunol; 1990 Jul; 20(7):1423-8. PubMed ID: 2143724 [TBL] [Abstract][Full Text] [Related]
14. Sialophorin, a surface sialoglycoprotein defective in the Wiskott-Aldrich syndrome, is involved in human T lymphocyte proliferation. Mentzer SJ; Remold-O'Donnell E; Crimmins MA; Bierer BE; Rosen FS; Burakoff SJ J Exp Med; 1987 May; 165(5):1383-92. PubMed ID: 3572301 [TBL] [Abstract][Full Text] [Related]
15. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome. Park JK; Rosenstein YJ; Remold-O'Donnell E; Bierer BE; Rosen FS; Burakoff SJ Nature; 1991 Apr; 350(6320):706-9. PubMed ID: 2023632 [TBL] [Abstract][Full Text] [Related]
16. Isolation and partial characterization of ascites sialoglycoprotein-2 of the cell surface sialomucin complex of 13762 rat mammary adenocarcinoma cells. Hull SR; Sheng Z; Vanderpuye O; David C; Carraway KL Biochem J; 1990 Jan; 265(1):121-9. PubMed ID: 2302161 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. Greer WL; Higgins E; Sutherland DR; Novogrodsky A; Brockhausen I; Peacocke M; Rubin LA; Baker M; Dennis JW; Siminovitch KA Biochem Cell Biol; 1989 Sep; 67(9):503-9. PubMed ID: 2803729 [TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. Carlsson SR; Fukuda M J Biol Chem; 1986 Sep; 261(27):12779-86. PubMed ID: 2943740 [TBL] [Abstract][Full Text] [Related]
19. Interaction of sialoglycoproteins with wheat germ agglutinin-sepharose of varying ratio of lectin to Sepharose. Use for the purification of mucin glycoproteins from membrane extracts. Furukawa K; Minor JE; Hegarty JD; Bhavanandan VP J Biol Chem; 1986 Jun; 261(17):7755-61. PubMed ID: 3711107 [TBL] [Abstract][Full Text] [Related]